Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of condition-specific biomarker systems in uterine cancer. | G3 (Bethesda) | 2022 | 34791179 | PubTator, text mining | PubMed |
| Design, Synthesis, and Functional Evaluation of 1, 5-Disubstituted Tetrazoles as Monoamine Neurotransmitter Reuptake Inhibitors. | Biomol Ther (Seoul) | 2022 | 34789584 | PubTator, text mining | PubMed |
| Systems genetics analysis defines importance of TMEM43/LUMA for cardiac- and metabolic-related pathways. | Physiol Genomics | 2022 | 34766515 | PubTator, text mining | PubMed |
| Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies. | Exp Cell Res | 2022 | 34740639 | PubTator, text mining | PubMed |
| ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. | Blood | 2022 | 34727172 | PubTator, text mining | PubMed |
| NTRK-Fusion Sarcoma of the Uterine Cervix: Report of 2 Cases With Comparative Clinicopathologic Features. | Int J Gynecol Pathol | 2022 | 34723848 | PubTator, text mining | PubMed |
| A Japanese Patient with Hereditary Myopathy with Early Respiratory Failure Due to the p.P31732L Mutation of Titin. | Intern Med | 2022 | 34670883 | PubTator, text mining | PubMed |
ROS1 rearrangements in non-small cell lung cancer: screening by immunohistochemistry using proportion of cells staining without intensity and excluding cases with MAPK pathway drivers improves test performance. | Pathology | 2022 | 34635319 | PubTator, text mining | PubMed |
| Integrating SNPs-based genetic risk factor with blood epigenomic response of differentially arsenic-exposed rural subjects reveals disease-associated signaling pathways. | Environ Pollut | 2022 | 34619179 | PubTator, text mining | PubMed |
| G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs). | Pharmacol Ther | 2022 | 34480967 | PubTator, text mining | PubMed |
| Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing. | J Clin Pathol | 2022 | 33875457 | PubTator, text mining | PubMed |
| Clinico-pathological features and mutational spectrum of 16 nemaline myopathy patients from a Chinese neuromuscular center. | Acta Neurol Belg | 2022 | 33742414 | PubTator, text mining | PubMed |
| On the Role of a Conserved Methionine in the Na+-Coupling Mechanism of a Neurotransmitter Transporter Homolog. | Neurochem Res | 2022 | 33565025 | PubTator, text mining | PubMed |
| Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome. | Fam Cancer | 2022 | 33219493 | PubTator, text mining | PubMed |
| Predicted structure of fully activated human bitter taste receptor TAS2R4 complexed with G protein and agonists. | QRB Discov | 2021 | 37529671 | PubTator, text mining | PubMed |
| LncRNA WEE2-AS1 knockdown inhibits the proliferation, migration and invasion of glioma cells via regulating miR-29b-2-5p/TPM3 axis. | Oncol Res | 2021 | 37305396 | PubTator, text mining | PubMed |
| The making of a potent L-lactate transport inhibitor. | Commun Chem | 2021 | 36697570 | PubTator, text mining | PubMed |
| A Case Report of Genetic Cascade Screening in Dilated Cardiomyopathy: A Perspective for Preventive Cardiology. | Iran J Public Health | 2021 | 36317039 | PubTator, text mining | PubMed |
| BRANEart: Identify Stability Strength and Weakness Regions in Membrane Proteins. | Front Bioinform | 2021 | 36303753 | PubTator, text mining | PubMed |
| Correction: In silico decryption of serotonin-receptor binding: local non-covalent interactions and long-range conformational changes. | RSC Adv | 2021 | 35426993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=46